Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT05929196 Completed - Diabetes Clinical Trials

Feasibility Evaluation - Blood Glucose Level Monitoring by Microwave Metamaterial Sensor in Blood Samples.

Start date: July 12, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test microwave metamaterial glucose sensor on blood samples. It means to compare the results of glucose values obtained by microwave metamaterial sensor and by standard biochemical analyzer.

NCT ID: NCT05928637 Completed - Diabetes type2 Clinical Trials

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150

Start date: July 10, 2023
Phase: Phase 1
Study type: Interventional

A clinical trial to compare the pharmacokinetic characteristics and safety among D745, D759, and D150 in healthy subjects

NCT ID: NCT05925829 Completed - Clinical trials for Diabetes Mellitus, Type 2

Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes

Start date: January 1, 2017
Phase: Phase 1
Study type: Interventional

This study was a retrospective study on type 2 diabetes patients that were treated with autologous stromal vascular fraction (SVF) and autologous activated platelet-rich plasma (aaPRP) measuring HbA1c level at baseline, 1-month, 3-month, 6-month, and 12-month post-treatment.

NCT ID: NCT05921461 Completed - Diabetes Mellitus Clinical Trials

The Use of HOVR Technology for Assessment of Blood Associated Parameters

Start date: May 1, 2022
Phase:
Study type: Observational

Feasibility, usability and safety clinical study that is aimed at testing of the non-invasive VOTIS PedCheck system for measurement of changes in absorption of light in order to derive changes in perfusion and oxygen levels in the foot.

NCT ID: NCT05919667 Completed - Obesity Clinical Trials

Dairy and Non-Dairy Alternatives Comparative on Metabolic Outcomes

Start date: February 28, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the acute effects of a single serving of dairy and non-dairy alternatives on post-treatment and post-meal glycemia, appetite, plasma amino acid concentrations, and gastrointestinal hormones levels.

NCT ID: NCT05918653 Completed - Diabetes Mellitus Clinical Trials

Demographic, Clinical, and Biomedical Profile of Diabetic Patients Receiving Home Healthcare in Saudi Arabia

Start date: December 15, 2022
Phase:
Study type: Observational [Patient Registry]

Background: Identifying characteristics of diabetic patients receiving home healthcare will help in designing services that respond to their conditions and improve their health status and quality of life. The aim of this study is to describe demographic, clinical, and biomedical characteristics of diabetic patients receiving home healthcare. Methodology: Descriptive cross-sectional study was conducted in King Salman Hospital in Riyadh, and Al Madinah home healthcare center in Saudi Arabia. The study Population included diabetic patients receiving home healthcare from these two health institutions. The inclusion criteria were type 1 and type 2 diabetes mellitus, all age groups, both males and females. A sample of 239 diabetic patients was selected using the stratified random sampling technique. Data were collected from the medical records of the eligible, selected study population using a structured data collection sheet. Data were analysed by statistical Package for the Social Sciences (SPSS) version 21. Categorical data were expressed as percentages with 95% confidence intervals, continuous data as mean and standard deviations.

NCT ID: NCT05918068 Completed - Clinical trials for Diabetes Mellitus, Type 2

Pyridoxine Effect on the Blood Glucose Level in Type 2 Diabetic Patients

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Pyridoxal-5-phosphate (P.L.P.), the biologically active form of vitamin B6, is a coenzyme in 150 enzymatic reactions, including amino acid, carbohydrate, and lipid metabolism. Neurotransmitter production and breakdown depend on it. Additionally, it functions as an antioxidant by suppressing reactive oxygen species and mitigating the development of advanced glycation end products. Humans recycle P.L.P. from dietary B6 vitamins, and this molecule has been related to various clinically relevant diseases. Pyridoxine as an additional therapy for type 2 diabetes will be examined in this study.

NCT ID: NCT05915884 Completed - Diabetes Clinical Trials

The Triglyceride/Glucose Index and SGLT-2 Inhibitors

Start date: June 10, 2023
Phase:
Study type: Observational

This study was designed to evaluate the change in triglyceride glucose index, one of the atherosclerotic markers, in patients with type 2 DM followed in the Internal Medicine Clinic of Samsun University, Samsun Training, and Research Hospital. Methods: The data of the patients who were followed up for at least 3 months by making a retrospective file review will be recorded and analyzed. It is planned to start the study following the ethics committee's approval.

NCT ID: NCT05915338 Completed - Diabetes type2 Clinical Trials

Training on Using ıInsulin in Patients With Type 2 Diabetes

INSÜLIN
Start date: October 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.

NCT ID: NCT05902546 Completed - Diabetes Mellitus Clinical Trials

Effect of HIIT Vs Moderate Intensity Aerobic Exercise on Insulin Resistance in Type 2 DM

Start date: January 7, 2023
Phase: N/A
Study type: Interventional

Comparing between the efficacy of high intensity interval training and moderate intensity aerobic exercises on insulin resistance in type 2 Diabetes Mellitus.